Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.06B
+39.6% from 2023
Prescriptions
72K
$14,690.96 per claim
Patients
11K
6,693 prescribers
Total spending, 2024
$1.06B
$94,025.92 per patient
Medicare prescription drug plans paid $1.06B for Verzenio in 2024, for 71,925 prescriptions and refills to 11,237 patients (up 39.6% from 2023). The average cost per claim was $14,690.96.
California had the highest Medicare cost for Verzenio in 2024: $120.6M for 8,246 claims, followed by Texas ($89.4M).
Christina L Bi, pharmacist in Roseville, CA, had the highest Medicare cost for Verzenio in 2024: 133 claims costing $2.2M.
Verzenio is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Christina L Bi Roseville, CA | Pharmacist | 133 | 19 | $2.2M |
| Rupa Subramanian Vista, CA | Hematology-Oncology | 149 | 15 | $2.1M |
| Susan M Newman |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 4,277 | 33,783 | 6,040 | $474.0M |
| 2023 | 5,503 | 50,457 | 8,213 | $756.7M |
| 2024 | 6,693 | 71,925 | 11,237 | $1.06B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 146 |
| 19 |
| $2.1M |
| Ruemu E Birhiray Indianapolis, IN | Hematology-Oncology | 143 | 16 | $2.1M |
| Luis Baez Vallecillo San Juan, PR | Hematology-Oncology | 132 | 15 | $2.1M |
| Gregory Vidal Germantown, TN | Medical Oncology | 125 | 22 | $1.9M |
| Seth D Cohen West Long Branch, NJ | Hematology-Oncology | 133 | 16 | $1.8M |
| Regan D Rostorfer Ocoee, FL | Hematology | 117 | 17 | $1.8M |
| Chiara Battelli Westbrook, ME | Hematology-Oncology | 126 | 15 | $1.7M |
| Tammy H Young Jackson, MS | Hematology-Oncology | 111 | 17 | $1.7M |
| Vipin Ramprasad Lohiya Fayetteville, GA | Hematology-Oncology | 108 | 14 | $1.6M |
| Aisha Ahmed Tucson, AZ | Hematology-Oncology | 101 | 17 | $1.5M |
| Christina Fitzmaurice Bend, OR | Hematology-Oncology | 105 | 12 | $1.5M |
| Jamie E McKenzie Tampa, FL | Medical Oncology | 100 | 13 | $1.4M |
| Kathy Sam Houston, TX | Hematology-Oncology | 90 | 13 | $1.4M |
| Dawn L Klemow Dallas, TX | Hematology-Oncology | 88 | 12 | $1.2M |
| Abdalla M Sholi Williamsport, PA | Hematology-Oncology | 79 | 11 | $1.2M |
| Michael A Danso Norfolk, VA | Medical Oncology | 78 | 14 | $1.2M |
| Kewen Z Jauss Little Rock, AR | Hematology-Oncology | 78 | Under 11 | $1.2M |
| Patricia Defusco Avon, CT | Medical Oncology | 84 | Under 11 | $1.2M |
| Avanti Mehrotra Robbinsdale, MN | Medical Oncology | 89 | 14 | $1.2M |
| Caroline A Rivera Olmo Vega Baja, PR | Hematology-Oncology | 74 | 13 | $1.2M |
| Richard S Zelkowitz Norwalk, CT | Hematology-Oncology | 74 | 13 | $1.1M |
| Daniel G Cameron Mobile, AL | Medical Oncology | 81 | Under 11 | $1.1M |
| Sonia M Benn Southaven, MS | Medical Oncology | 83 | 17 | $1.1M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Eli Lilly & Co. LLY | 71,933 | $1.06B |